Purpose objectives To conduct a comprehensive review of the controversies associated with tamoxifen, specifically the increased incidence of benign conditions of the uterus and endometrial cancer, tamoxifen s common side effects, the Breast Cancer Prevention Trial, and screening recommendations for endometrial cancer
stromectol dosage All the data were generated from at least three independent experiments